Microba Life Sciences Limited (ASX: MAP)
Australia
· Delayed Price · Currency is AUD
0.195
+0.010 (5.41%)
Dec 27, 2024, 3:28 PM AEST
Microba Life Sciences Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
Net Income | -19.94 | -19.94 | -12.68 | -11.47 | -7.52 | -6.65 | Upgrade
|
Depreciation & Amortization | 1.93 | 1.93 | 1.64 | 1.15 | 0.83 | 0.81 | Upgrade
|
Other Amortization | 0.94 | 0.94 | - | 0.39 | 0.39 | 0.28 | Upgrade
|
Loss (Gain) From Sale of Assets | 0 | 0 | 0.02 | 0.02 | - | - | Upgrade
|
Stock-Based Compensation | 0.69 | 0.69 | 0.42 | 0.64 | 0.56 | 0.45 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | -0.17 | - | - | Upgrade
|
Other Operating Activities | -0.18 | -0.18 | -0.18 | -0.76 | -0.15 | -0.01 | Upgrade
|
Change in Accounts Receivable | -0.01 | -0.01 | -3.81 | -1.77 | -1.03 | -0.46 | Upgrade
|
Change in Inventory | -0.31 | -0.31 | -0.28 | 0.15 | -0.17 | -0.17 | Upgrade
|
Change in Accounts Payable | 0.21 | 0.21 | 2.11 | 1.37 | 0.45 | 0.55 | Upgrade
|
Change in Unearned Revenue | 0.47 | 0.47 | 0.42 | -0.23 | 0.03 | - | Upgrade
|
Change in Income Taxes | 0 | 0 | 0.01 | - | - | - | Upgrade
|
Change in Other Net Operating Assets | 0.71 | 0.71 | -0.06 | 0.23 | -0.57 | 0.89 | Upgrade
|
Operating Cash Flow | -15.57 | -15.57 | -12.39 | -10.45 | -7.18 | -4.32 | Upgrade
|
Capital Expenditures | -1.49 | -1.49 | -0.55 | -1.64 | -0.25 | -0.36 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | - | Upgrade
|
Cash Acquisitions | -9.57 | -9.57 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -2.89 | -2.89 | -2.49 | -0.24 | -0.43 | -0.5 | Upgrade
|
Other Investing Activities | - | - | 0.04 | 0.13 | 0.1 | - | Upgrade
|
Investing Cash Flow | -13.95 | -13.95 | -3 | -1.73 | -0.57 | -0.86 | Upgrade
|
Short-Term Debt Issued | 0.49 | 0.49 | 0.48 | 0.43 | - | - | Upgrade
|
Total Debt Issued | 0.49 | 0.49 | 0.48 | 0.43 | - | - | Upgrade
|
Short-Term Debt Repaid | -0.43 | -0.43 | -0.48 | -0.22 | - | - | Upgrade
|
Long-Term Debt Repaid | -0.77 | -0.77 | -0.55 | -0.33 | -0.36 | -0.33 | Upgrade
|
Total Debt Repaid | -1.2 | -1.2 | -1.03 | -0.55 | -0.36 | -0.33 | Upgrade
|
Net Debt Issued (Repaid) | -0.71 | -0.71 | -0.55 | -0.13 | -0.36 | -0.33 | Upgrade
|
Issuance of Common Stock | 20.36 | 20.36 | 17.83 | 31.25 | 15.14 | 1.4 | Upgrade
|
Other Financing Activities | -1.26 | -1.26 | -0.6 | -1.9 | -0.95 | 0.01 | Upgrade
|
Financing Cash Flow | 18.39 | 18.39 | 16.68 | 29.22 | 13.84 | 1.08 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.03 | -0.03 | 0.17 | 0.57 | - | - | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | - | Upgrade
|
Net Cash Flow | -11.15 | -11.15 | 1.46 | 17.6 | 6.08 | -4.1 | Upgrade
|
Free Cash Flow | -17.05 | -17.05 | -12.94 | -12.08 | -7.43 | -4.68 | Upgrade
|
Free Cash Flow Margin | -141.06% | -141.06% | -238.82% | -257.75% | -199.04% | -161.02% | Upgrade
|
Free Cash Flow Per Share | -0.04 | -0.04 | -0.04 | -0.05 | -0.04 | -0.03 | Upgrade
|
Cash Interest Paid | 0.07 | 0.07 | 0.06 | 0.06 | 0.02 | 0.04 | Upgrade
|
Cash Income Tax Paid | 0.03 | 0.03 | 0 | 0.01 | - | - | Upgrade
|
Levered Free Cash Flow | -14.65 | -14.65 | -15.4 | -10.46 | -6.21 | -3.19 | Upgrade
|
Unlevered Free Cash Flow | -14.61 | -14.61 | -15.37 | -10.43 | -6.2 | -3.17 | Upgrade
|
Change in Net Working Capital | -2.36 | -2.36 | 1.75 | 0.57 | 1.36 | -0.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.